Reginald Sanders's most recent trade in EyePoint Pharmaceuticals Inc was a trade of 80,000 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Jan. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| EyePoint Pharmaceuticals Inc | Reginald Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2025 | 80,000 | 80,000 | - | - | Stock Options (Right to buy) |